|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
Effexor & Effexor XR (Venlafaxine Hydrochloride) Immediate & Extended Release Capsules, Wyeth-Ayerst NDA 20-151/S16, S19, S20, S21, S22, S23, S25 & 20-699/S14, S18, S21, S23, S26, S27, S34 1/31/03 2/12/03 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, 37.5 mg, 75 mg, and 150 mg, Wyeth-Ayerst NDA 20-699/S-015, S016, 20-151/S017, S018 5/2/01 7/30/03 4/25/03 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, 37.5 mg, 75 mg, and 150 mg, Wyeth-Ayerst NDA 20-699/S-032 2/26/03 3/10/03 Effexor, Wyeth-Ayerst NDA 20-151/S17 & S18 5/2/01 4/23/03 Effexor XR, Wyeth-Ayerst NDA 20-151/S15 & S16 5/2/01 Effexor Indications: Prevention o relapse and recurrence of depression. Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth-Ayerst NDA 20-699/S-022 2/11/03 2/12/03 2/13/03 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth-Ayerst NDA 20-699/S-029 10/22/02 10/28/02 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules. Wyeth-Ayerst Research NDA 20-699/S-001 3/11/99 3/22/99 3/22/99 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules. Wyeth-Ayerst Research NDA 20-699/S-038 & S-043 Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth Pharmaceuticals Effexor & Effexor XR (Venlafaxine Hydrochloride) Immediate & Extended Release Tablets & Capsules, Wyeth Pharmaceuticals Effexor & Effexor XR (Venlafaxine Hydrochloride) Immediate & Extended Release Tablets & Capsules,Wyeth Pharmaceuticals Effexor, Wyeth Pharmaceuticals, Inc., NDA 020699S030 Effexor (venlafaxine hydrochloride) Immediate Release Tablets & Extended Release Capsules, Wyeth Pharmaceuticals | Effexor (venlafaxine hydrochloride) Immediate Release, Wyeth Pharma, Labeling Revision | Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth Pharma, Labeling Revision | Effexor XR (venlafaxine HCL) Extended-Release Capsules, Wyeth Pharma, Patient Population Altered | Effexor (venlafaxine hydrochloride) Immediate Release Tablets, Wyeth Pharma, Labeling Revision | Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth Pharma, Labeling Revision | Effexor (venlafaxine hydrochloride) Immediate Release Tablets, Wyeth Pharma, Labeling Revision | Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth Pharma, Labeling Revision | Effexor XR Extended Release capsule, Wyeth Pharma, Package Change | Venlafaxine Hydrochloride Tablets, Teva Pharma, Approval | Venlafaxine Hydrochloride Tablets, Mylan Pharma, Approval | Effexor (venlafaxine hydrochloride) Immediate Release Tablets, Wyeth Pharma, Labeling Revision | Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth Pharma, Labeling Revision | Effexor (venlafaxine hydrochloride) Immediate Release Tablets, Wyeth Pharma, Labeling Revision | Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth Pharma, Labeling Revision | Effexor (venlafaxine hydrochloride) Immediate Release Tablets, Wyeth Pharma, Labeling Revision | Effexor XR (venlafaxine hydrochloride) Extended Release Capsules, Wyeth Pharma, Labeling Revision | Venlafaxine Hydrochloride Tablets, Dr. Reddy’s Labs, Tentative Approval | Venlafaxine Hydrochloride Tablets, Zydus Pharma, Tentative Approval
|